AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...

Beyond breast cancer, the potential for Dato-DXd in lung cancer ... Begin your TipRanks Premium journey today. Daiichi Sankyo Company (DSKYF) Company Description: Daiichi Sankyo Co., Ltd. engages ...

A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug ... Datroway, also called datopotamab deruxtecan, or Dato-DXd, was approved in Japan for a form ...

Narrow-moat Daiichi Sankyo’s third-quarter earnings were in line with our expectations. Despite its change in development strategy for recently approved Datroway (formerly known as Dato-DXd), we ...

AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...

for datopotamab deruxtecan (Dato-DXd), an ADC targeting EGFR-mutated non–small cell lung cancer (NSCLC) developed by Daiichi Sankyo and AstraZeneca.

AstraZeneca and Daiichi Sankyo have claimed FDA approval for a ... The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a treatment ...

AstraZeneca and Daiichi Sankyo voluntarily withdraw regulatory filing for Dato-DXd in nonsquamous non-small cell lung cancer in the European Union. TOKYO & MUNICH, December 24, 2024--Daiichi ...

Still, AstraZeneca and Daiichi Sankyo are optimistic about the use of Datroway to treat some patients with breast and lung cancers. The drug, also called Dato-DXd, is among a group that ...

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK ... Datroway (datopotamab deruxtecan or Dato-DXd) has been approved in the US for the treatment of adult ...

AstraZeneca and Daiichi Sankyo won U.S. approval for a novel breast ... The drug, also called Dato-DXd, is among a group that Astra is counting on for peak annual sales of at least $5 billion ...